Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116

Glycobiology

Volumn 19, Issue 4, 2009, Pages 437-450

  Kawasaki, Nobuko ^a   Lin, Chia Wei ^b,c   Inoue, Risa ^a   Khoo, Kay Hooi ^b,c   Kawasaki, Nana ^d   Ma, Bruce Yong ^a   Oka, Shogo ^e   Ishiguro, Masaji ^f   Sawada, Toshihiko ^g   Ishida, Hideharu ^g   Hashimoto, Tomohiro ^g   Kawasaki, Toshisuke ^a  

^a RITSUMEIKAN UNIVERSITY   (Japan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

^g GIFU UNIVERSITY   (Japan)

Author keywords

CD26; Lea epitope; Mannan binding lectin; Mannan binding protein; SW1116

Indexed keywords

CD98 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLYCAN; GLYCOSIDASE; LIGAND; MANNAN BINDING LECTIN;

ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME METABOLISM; EPITOPE MAPPING; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; TANDEM REPEAT;

ANTIGENS, CD26; ANTIGENS, CD98 HEAVY CHAIN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EPITOPES; FUCOSE; GLYCOSYLATION; HUMANS; LIGANDS; MANNOSE-BINDING LECTIN; MODELS, MOLECULAR; NEOPLASM PROTEINS; OLIGOSACCHARIDES; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 62349133903     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn158     Document Type: Article

References (31)

1. Aertgeerts K, Ye S, Shi L, Prasad SG, Witmer D, Chi E, Sang B-C, Wijnands RA, Webb DR, Swanson RV. 2004. N-Linked glycosylation of dipeptidyl peptidase IV (CD26): Effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Protein Sci. 13(1):145-154.
2. Asano S, Kameyama M, Oura A, Morisato A, Sakai H, Tabuchi Y, Chairoungdua A, Endou H, Kanai Y. 2007. L-Type amino acid transporter-1 expressed in human astrocytomas, U343MGa. Biol Pharm Bull. 30(3):415-422.
3. Dell A, Reason AJ, Khoo K-H, Panico M, McDowell RA, Morris HR. 1994. Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol. 230:108-132.
4. Dommett RM, Klein N, Turner MW. 2006. Mannose-binding lectin in innate immunity: Past, present and future. Tissue Antigens. 68(3):193-209.
5. Esseghir S, Reis-Filho JS, Kennedy A, James M, O'Hare MJ, Jeffery R, Poulsom R, Isacke CM. 2006. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J Pathol. 210(4):420-430.
6. Fan Y-Y, Yu S-Y, Ito H, Kameyama A, Sato T, Lin C-H, Yu L-C, Narimatsu H, Khoo K-H. 2008. Identification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses. J Biol Chem. 283(24):16455-16468.
7. Hara K, Kudo H, Enomoto T, Hashimoto Y, Masuko T. 2000. Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/ CD98 heavy chain. Oncogene. 19(54):6209-6215.
8. Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C, Dang NH. 2008. The role of CD26/dipeptidyl peptidase IV in cancer. Front Biosci. 13(5):1634-1645.
9. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. 1999. Phylogenetic perspectives in innate immunity. Science. 284(5418):1313-1318.
10. Huang J, Byrd JC, Yoon WH, Kim YS. 1992. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Oncol Res. 4(11-12):507-515.
11. Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. 1987. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem. 262(16):7451-7454.
12. Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, Inamoto S, Katsuoka Y, Hosono O, Tanaka H, et al. 2007. Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res. 13(14):4191-4200.
13. kip1enhancement, and disruption of binding to the extracellular matrix. Clin Cancer Res 12(11):3470-3477.
14. Iwata S, Morimoto C. 1999. CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. J Exp Med. 190(3):301-305.
15. Kawasaki N, Kawasaki T, Yamashina I. 1983. Isolation and characterization of a mannan-binding protein from human serum. J Biochem. 94(3):937-947.
16. Kawasaki N, Kawasaki T, Yamashina I. 1989. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem. 106(3):483-489.
17. Kawasaki T. 1999. Structure and biology of mannan-binding protein, MBP, an important component of innate immunity. Biochim Biophys Acta. 1473(1):186-195.
18. Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. 1999. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding protein dependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA. 96(2):371-375.
19. Malhotra R, Lu J, Holmskov U, Sim RB. 1994. Collectins, collectin receptors and the lectin pathway of complement activation. Clin Exp Immunol. 97(Suppl. 2):4-9.
20. Muto S, Sakuma K, Taniguchi A, Matsumoto K. 1999. Human mannose-binding lectin preferentially binds to human colon adenocarcinoma cell lines expressing high amount of Lewis A and Lewis B antigens. Biol Pharm Bull. 22(4):347-352.
21. Ohnuma K, Ishii T, Iwata S, Hosono O, Kawasaki H, Uchiyama M, Tanaka H, Yamochi T, Dang NH, Morimoto C. 2002. G1/S cell cycle arrest provoked in human T cells by antibody to CD26. Immunology. 107(3):325-333.
22. Ohta M, Kawasaki T. 1994. Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans. Glycoconj J. 11(4):304-308.
23. Pedretti A, Villa L, Vistoli G. 2002. VEGA: A versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model. 21(1):47-49.
24. Pro B, Dang NH. 2004. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histpathol. 19(4):1345-1351.
25. Rao VSR, Qasba PK, Balaji PV, Chandrasekaran R. 1998. Conformation of Carbohydrates. Amsterdam: Harwood Academic Publishers.
26. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet. 2(8674):1236-1239.
27. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. 2005. The mannose-binding lectin: A prototypic pattern recognition molecule. Curr Opin Immunol 18(1):16-23.
28. Taylor ME, Drickamer K. 2007. Paradigms for glycan-binding receptors in cell adhesion. Curr Opin Cell Biol. 19(5):572-577.
29. Terada M, Khoo K-H, Inoue R, Chen C-I, Yamada K, Sakaguchi H, Kadowaki N, Ma BY, Oka S, Kawasaki T, et al. 2005. Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N glycan. J Biol Chem. 280(12):10897-10913.
30. Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A. 1985. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem. 260(8):4688-4693.
31. Yuriev E, Farrugia W, Scott AM, Ramsland PA. 2005. Three-dimensional structures of carbohydrate determinants of Lewis system antigens: Implications for effective antibody targeting of cancer. Immunol Cell Biol. 83(6):709-717.